BB's Stock Haven

[FullGlass]

GNBP released a 10K on Friday and I have found it to show that the company potentially has a lot in store for the upcoming 2012-2013 year! The company has aligned itself with the National Cancer Institute (NCI) where GNBP has entered into a Patent License Agreement with the National Institutes of Health, giving GNBP the non-exclusive worldwide right and license to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products for the treatment of metastatic melanoma, ovarian cancer, breast cancer, and colorectal cancer.